Key facts
- Lifescapes’s last known valuation is $18.8M (Nov 2022).
- It has raised $9.1M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Mitsubishi UFJ Capital, Nippon Venture Capital, Mitsui Sumitomo Insurance Co., Beyond Next Ventures, Keio Innovation Initiative — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Lifescapes
- ·The full record, as it builds
Funding rounds
No funding rounds for Lifescapes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lifescapes
Developer of brain-machine interface devices designed to be used for neurorehabilitation. The company's devices can conduct brain-wave data extraction and analysis by detecting the activity of the functional compensation circuit in real-time from the extracted data of the stroke patient driving the robot attached to the paralyzed part and creating a neural circuit for moving the body, enabling healthcare professionals to help patients recover from movement disorders.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2018
- Employees
- 15
- Website
- lifescapes.jp/
- Ownership
- Privately Held (backing)
Lifescapes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lifescapes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lifescapes in its N-PORT filings yet. We sweep new filings monthly.